DCF — PROVIDENCE WILLAMETTE FALLS MED CTR
Enterprise Value: $-283.1M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-283.1M
Enterprise Value
$-89.1M
PV of Cash Flows
$-194.1M
PV of Terminal Value
$-312.5M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $162.5M | $-17.9M | -11.0% | $-24.8M | $-22.5M |
| Year 2 | $167.4M | $-16.8M | -10.0% | $-23.9M | $-19.7M |
| Year 3 | $172.4M | $-15.6M | -9.0% | $-22.8M | $-17.2M |
| Year 4 | $177.6M | $-15.1M | -9.0% | $-22.6M | $-15.5M |
| Year 5 | $182.9M | $-15.1M | -8.0% | $-22.9M | $-14.2M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-283.1M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$157.8M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.11520173715652655
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5